Ginkgo Bioworks Holdings, Inc. (DNA) |
|
2.66 0.28 (11.76%)
|
05-16 07:57 |
|
Open: |
2.51 |
Pre. Close: |
2.38 |
|
High:
|
2.76 |
Low:
|
2.45 |
|
Volume:
|
33,743,217 |
Market Cap:
|
4,721(M) |
|
|
|
|
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.76 - 2.78 |
2.78 - 2.79 |
|
Low:
|
2.42 - 2.43 |
2.43 - 2.45 |
|
Close:
|
2.63 - 2.66 |
2.66 - 2.68 |
|
Technical analysis |
as of: 2022-05-16 7:47:30 AM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 3.81 One year: 4.65 |
| Support: |
Support1: 2.09 Support2: 1.74 |
| Resistance: |
Resistance1: 3.26 Resistance2: 3.98 |
| Pivot: |
2.87  |
| Moving Average: |
MA(5): 2.46  MA(20): 3.06
MA(100): 4.7 MA(250): 8.45 |
| MACD: |
MACD(12,26): -0.4 Signal(9): -0.3 |
| Stochastic oscillator: |
%K(14,3): 26 %D(3): 17.2 |
| RSI: |
RSI(14): 41.5 |
| 52-week: |
High: 15.86 Low: 2.09 |
| Average Vol(K): |
3-Month: 20,601 (K) 10-Days: 26,027 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ DNA ] has closed above bottom band by 37.3%. Bollinger Bands are 30.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 16 May 2022
Exploring phylogenetic relationships within the subgenera of Bambusa based on DNA barcodes and morphological characteristics | Scientific Reports - Nature.com
Mon, 16 May 2022
New York DNA measure touted as key to justice for violent cold cases - Bluefield Daily Telegraph
Mon, 16 May 2022
Sex offenders required forced into compliance with DNA requirement - Columbia Basin Herald
Mon, 16 May 2022
DNA Sequencing in Drug Discovery Market: increasing adoption of novel sequencing technologies to drive the market - BioSpace
Mon, 16 May 2022
Rangers' refusal to surrender mirrors 2015 team's winning DNA - New York Post
Sun, 15 May 2022
DNA Testing Identifies Remains Found In Colorado In 1994 As Susan Hoppes - CBS Denver
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. |
1,190 (M) |
| Shares Float |
318 (M) |
|
% Held by Insiders
|
7.5 (%) |
|
% Held by Institutions
|
73.4 (%) |
|
Shares Short
|
42,910 (K) |
|
Shares Short P.Month
|
18,720 (K) |
Stock Financials |
|
EPS
|
-8.7 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
1.03 |
|
Profit Margin (%)
|
-140 |
|
Operating Margin (%)
|
-100.9 |
|
Return on Assets (ttm)
|
0 |
|
Return on Equity (ttm)
|
0 |
|
Qtrly Rev. Growth
|
483.3 |
|
Gross Profit (p.s.)
|
0.05 |
|
Sales Per Share
|
0.16 |
|
EBITDA (p.s.)
|
-0.15 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-148 (M) |
|
Levered Free Cash Flow
|
0 (M) |
Stock Valuations |
|
PE Ratio
|
-0.31 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
2.55 |
|
Price to Sales
|
16.03 |
|
Price to Cash Flow
|
-21.45 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
